Home
Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 25/02/05
Trade details
- Type
- Insider sale
- Amount
- $41,136.85
- Shares · price
- 11,855 sh · $3.47 a share
- Held after
- 3,164,933 sh
- Person
- Justin B. KleeCo-CEO
- Trade date
- 25/02/03
- Filed
- 25/02/05
- Days to filing
- 2 days
Sold 0.4% of holdings
- Share of holding sold
- 0.4%
Amylyx Pharmaceuticals trades, last 26 weeks
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/01/04~25/03/05Justin B. Klee's recent trades
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$423.7K
29,282 sh
$423.7K
Filed 03/04
Traded 03/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
- Justin B. Klee
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
- Justin B. Klee
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02